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OBJECTIVE — Compare GHb among people with diabetes who have and have not received
periodontal care.
RESEARCH DESIGN AND METHODS — This cross-sectional study linked 5 years of
electronic medical record and dental insurance data for dually insured patients with diabetes,
ages 40–70 years (n  5,103). We assessed the association between annual mean GHb (%) and
periodontal care (a proxy for periodontitis) deﬁned using claim codes. Among patients who
received periodontal care, we assessed the association between GHb and periodontal treatment
intensity.Wedeterminedassociationsusinglinearregressionadjustedforpotentialconfounders
and tested for effect modiﬁcation by age, sex, insulin use, diabetes severity, BMI, and smoking.
RESULTS — MeanGHbwas7.66%;38%ofparticipantsreceivedperiodontalcareduringthe
5 years. After multivariate adjustment, patients who received periodontal care had a GHb level
0.08 percentage points higher than patients who did not (P  0.02). In stratiﬁed analyses, the
association was present for women (0.18 percentage points higher GHb with periodontal care,
P  0.001) but not signiﬁcant for men (0.008 percentage points lower, P  0.86). In patients
who received periodontal care, those with one, and with two or more, surgical treatments had
GHb 0.25 (P  0.04) and 0.36 (P  0.002) percentage points lower, respectively, than patients
without periodontal surgeries.
CONCLUSIONS — This population-based cross-sectional study showed small associations
between periodontal care (a proxy for periodontitis) and higher GHb. Well-controlled longitu-
dinal studies or clinical trials are needed to evaluate causality and temporal trends. Sub-analyses
suggest that further investigation of this association among women, and by intensity of peri-
odontal treatment, may be of interest.
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nestimated23.6millionAmericans
havediabetes,andtheprevalenceis
increasing. Periodontal disease may
have a systemic effect that could worsen
glycemic control. Reports have linked pe-
riodontitis to higher plasma levels of C-
reactive protein (1), interleukin-6 (2),
andtumornecrosisfactor-(2);thesefac-
tors have been associated with insulin re-
sistance, potentially worsening glycemic
control (3,4). Some investigators suggest
this association may be due to confound-
ing by shared causal factors such as an
unhealthy diet or smoking (5,6).
Observational studies have assessed
the association between periodontal dis-
ease and GHb in patients with type 2 di-
abetes. Most (7–13) but not all (14)
studiessuggestanassociationwithhigher
GHb. These studies were typically small
and were often performed in patient
groups subject to selection biases. The
impact of periodontal treatment on glyce-
mic control is controversial, with two
meta-analyses reporting conﬂicting re-
sults (15,16), reﬂecting the biases that
may plague these small studies.
We sought to examine these associa-
tions in a large population-based cross-
sectional study. Our primary hypothesis
was that GHb levels would be higher in
participants with claims for periodontal
care(aproxyforperiodontitis).Asecond-
ary hypothesis was that, in patients who
received periodontal care, GHb levels
would be lower in patients who received
higher-intensity treatment.
RESEARCH DESIGN AND
METHODS— Data were extracted
from automated dental and medical data-
bases. Instead of the usual 1-year study
period, we used 5 years, to ensure ade-
quatetimeforparticipantstoreceiveboth
dental and medical care. Figure 1 shows
the inclusion and exclusion criteria. We
used four identiﬁers to link medical and
dental data for individuals aged 40–70
years who were continuously insured
from 2002 to 2006 by both the Washing-
ton Dental Service (a dental insurer) and
Group Health Cooperative (an integrated
health care system) in Washington state.
These procedures are described else-
where (17).
Diabetes was deﬁned as follows: two
fasting glucose levels 126 mg/dl, two
nonfasting glucose levels 200 mg/dl, or
one of each within 12 months; GHb
7.0%; any ﬁlled prescription for insulin
ororaldiabeticagents;oroneinpatientor
two outpatient diabetes diagnoses. We
excluded patients with gestational and
secondary diabetes (18). The population
with diabetes included both types 1 and
type 2 diabetes; but given the age-speciﬁc
prevalence,mostprobablyhavetype2di-
abetes (18). Group Health’s institutional
review board approved all procedures.
Our exposure variable, periodontal
care, was deﬁned by identifying any den-
tal claim submitted with at least one
Current Dental Terminology (CDT) peri-
odontalprocedurecodeduringthe5-year
study period. The CDT codes taken as ev-
idence of periodontal disease included
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val(D4240,D4241)andapically(D4245)
positionedﬂaps,osseoussurgery(D4260,
D4261), bone replacement graft (D4263,
D4264), tissue regeneration with biologic
materials(D4265),guidedtissueregener-
ation (D4266, D4267), periodontal scal-
ing/root planing (D4341, D4342,
D4345), full mouth debridement
(D4355), and localized antimicrobial de-
livery (D4381). Periodontal treatment in-
tensity was deﬁned by two variables: 1)
the occurrence and frequency of peri-
odontal surgeries (D4240, D4241,
D4245, D4260, D4261, D4263, D4264,
D4265,D4266,D4267)(0,1,2)and2)
an indicator (0/1) of whether the total
number of nonsurgical periodontal
claims (D4342, D4345, D4355, D4381,
D4910) was above the median (7). These
exposure variables were assigned once
during the 5-year period.
Potential confounders, extracted
fromthemedicaldatabases,includedage,
sex, and medical insurance type in 2002.
Smoking status, routinely collected at
medical visits, was deﬁned as nonsmoker
if clinical staff recorded patients as non-
smokers on 90% or more of their visits
during the 5-year period, continuous
smokers if 90% of visits were labeled as
smoking, and intermittent smokers for
the remainder. BMI recorded during clin-
icalvisitswascalculatedusingthemedian
oftheﬁrstthreemeasurementsduringthe
5-year period and categorized (24.9,
25–29.9, 30–39.9, and 40). To control
for potential utilization biases, we in-
cludedmarkersofmedicalcareuse(num-
ber of primary care/urgent visits [square
root], number of specialty visits [square
root], number of emergency visits [0, 1,
2], and the number of GHb tests per-
formed), and surrogate markers of pre-
ventive health care–seeking behaviors
(number of preventive [well-care] visits
[square root] and number of retinal eye
exams [square root]). We used RxRisk
scores to control for chronic disease co-
morbidity at the beginning of the study
(2002) (19). This score is based on an
individual’s age, sex, insurance status,
and chronic condition proﬁle measured
by outpatient pharmacy dispensing. Us-
ing pharmacy records, we classiﬁed dia-
betes treatment intensity during the
5-year period as “no diabetes medica-
tions,” “oral hypoglycemic only,” and
“any use of insulin.” We quantiﬁed diabe-
tes severity using the 11-point Diabetes
Complication Severity Index (0, 1, 1)
(20).
We used Pearson 
2 for categorical
variables and ANOVA F tests for contin-
uous variables to test differences in per-
centages and means of population
characteristics by periodontal care status.
The outcome variable, mean GHb
(%), was calculated for each study year.
While the distribution of annual mean
GHb (%) was right skewed, log transfor-
mation yielded similar results, and we
elected to use the untransformed mean to
ease interpretation. Because an individual
can have up to ﬁve annual GHb means
(2002–2006), we used generalized esti-
mating equations with an independence
working correlation structure to account
for within-person correlation. Some co-
variates had extremely high values and
were either categorized or square-root
transformed to reduce their inﬂuence on
Figure 1—Flow diagram showing study inclusion and exclusion criteria.
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with robust standard errors (regress com-
mand in STATA release 10) were used to
model annual mean GHb as a function of
single measures of periodontal care and
periodontal treatment intensity within
the 5-year period.
Our models were developed by ﬁrst
includingageandsexandthentestingthe
effect of additional covariates. All vari-
ablespotentiallyrelatedtoGHbwerethen
included to establish their association.
Nonsigniﬁcant variables were removed
oneatatime(indecreasingPvalueorder)
until only signiﬁcant variables remained.
BMI and the exposure variables were in-
cluded. Violations of the regression as-
sumptions were checked in the ﬁnal
model using a residual-versus-ﬁtted
plot. Variance inﬂation factors were as-
sessed to check for the presence of
multicollinearity.
In exploratory multivariate analysis,
we tested for interactions separately be-
tween periodontal care and each of the
following variables: diabetes complica-
tion severity, age (40–49 or 50–70
years), sex, any insulin use (2002–2006),
BMI, and smoking status (2002–2006).
We tested for effect modiﬁcation by BMI
andsmokingbasedonthehypothesisthat
inﬂammation associated with obesity or
smoking may obscure the association be-
tweenperiodontitisandglycemiccontrol.
We hypothesized that the association be-
tween periodontitis and glycemic control
maydifferbydiabetesseverity(treatment,
complication) because glycemic control
in more advanced disease may resist in-
ﬂuence. We stratiﬁed by age based on
ﬁndings from a previous study (13).
RESULTS— During the study period
(2002–2006), the mean GHb for our du-
al-insured population with diabetes (n 
5,103)was7.66%,theaverageagewas55
years, and 38% received periodontal care
(Table 1). Compared with participants
withoutperiodontalcare,thosewithperi-
odontal care were younger, used ambula-
tory services less, and were more likely to
smoke,havelowerBMI,andbemenorbe
on government-based insurance.
As hypothesized, multivariate analy-
ses linked periodontal care (a proxy for
periodontitis) with higher GHb levels. In
the unadjusted model, annual mean GHb
was 0.11 percentage points higher for
people with diabetes who received peri-
odontal care than for those receiving no
periodontal care (P  0.005) (Table 2).
The magnitude of the association de-
creased but remained statistically signiﬁ-
cantaftercontrollingforage,BMI,andsex
(GHb 0.09 percentage points higher; P 
0.02) as well as other variables related to
diabetes control, including comorbidity,
smoking, medical utilization (primary
care visits, specialty care visits, and GHb
tests), and number of preventive well-
carevisits(0.08percentagepointshigher;
P  0.04). The association was indepen-
dent of diabetes severity (0.08 percentage
points higher; P  0.02).
The periodontitis-GHb association
was similar within categories of smoking
status, BMI, and insulin use. However,
the magnitude of the association ap-
pearedgreaterinwomenthanmen(inter-
action term P  0.002) (Table 3). There
was also suggestion that the magnitude of
the association may be greater at younger
ages (40–49 years old).
Among diabetic patients with peri-
odontal care (n  1,950), 44% received
more than seven nonsurgical periodontal
services including periodontal mainte-
nance, local antimicrobials, and other
nonsurgical treatments. Surgical care was
relatively uncommon; 93% had no peri-
odontal surgeries, 4% had one, and 3%
had two or more. As hypothesized,
among individuals with periodontal care,
those who received greater treatment in-
tensity had lower GHb levels. In the ad-
justed model, people with more than the
median number (7) of nonsurgical visits
had GHb 0.13 percentage points lower
than individuals with seven or fewer non-
surgical visits (95% CI 0.24 to 0.03;
P  0.01). Compared with people with
noperiodontalsurgeries,thosewith1and
2 or more surgeries had GHb levels that
were 0.25 (95% CI 0.49 to 0.01; P 
0.04) and 0.36 (95% CI 0.58 to 0.13;
P  0.002) percentage points lower, re-
spectively. Similar ﬁndings were ob-
servedinanalyseslimitedtononsmokers.
Among nonsmokers, people with more
than the median number (7) of nonsurgi-
cal visits had GHb 0.14 percentage points
lower than individuals with fewer visits
(P  0.02). Compared with people with
no periodontal surgeries, those with one
and two or more surgeries had GHb lev-
els that were 0.26 (P  0.05) and 0.29
(P  0.006) percentage points lower,
respectively.
CONCLUSIONS— In our cross-
sectional study of 5,103 patients with di-
abetes, we observed a small association
between higher GHb and receipt of any
periodontal care provided by community
dentistsorperiodontists,afteraccounting
forconfounders.Theassociationbetween
periodontalcareandglycemiccontrolcan
reﬂect either periodontitis itself or treat-
ment for the disease. Treatment for peri-
odontitiscouldworsencertainmarkersof
glycemic control possibly linked to a
short-term increase of inﬂammatory
markers(21)orduetotheincreaseinfast-
ingplasmaglucosethatmayhappenupon
resolution of certain infections. If peri-
odontal care is a marker of periodontitis
(which is our primary hypothesis), our
results are consistent with a small body of
observational evidence linking periodon-
titis and poor glycemic control in ad-
justed analyses. A Swedish population-
based study of 179 participants with type
2 diabetes reported a 0.6% difference in
GHb between patients with and without
periodontitisdeﬁnedbythepercentageof
teeth with 30% bone loss (9). One multi-
variate analysis found an association be-
tween GHb and probing depth but not
attachment loss (11), while another
linked GHb to attachment loss but not to
probing depth (14). In a cohort study of
88participantsofPimaancestrywithtype
2diabetes,attachmentlosswasassociated
withasixfoldincrease(95%CI1.5–25)in
the odds of GHb 9% after 2 years of
follow-up (13).
These smaller studies found stronger
associations between periodontitis and
GHb than we found between periodontal
care and GHb. This difference may relate
to our use of periodontal care as a marker
of periodontitis. However, we believe this
assumption is reasonable for several rea-
sons:1)allparticipantswereexaminedby
a dentist; 2) in our prior validation analy-
sis, the positive predictive value, sensitiv-
ity, and speciﬁcity were 84, 80, and 44%,
respectively, when the periodontal care
code set was compared with chart prob-
ingdepthof5mmontwoormoreteeth
in a subset with periodontal charts (22);
3) the proportion of patients receiving
periodontal care in our study (38%) re-
sembles the Centers for Disease Control
and Prevention (CDC) estimate of 30% of
people with diabetes having severe peri-
odontal diseases; (23) and 4) when peri-
odontal codes were categorized by
intensity and evaluated in patients who
received periodontal care, we saw slightly
lower GHb among individuals who re-
ceived higher treatment intensity. How-
ever, we could not identify people with
periodontitis who did not receive peri-
odontalcare.Thismisclassiﬁcationwould
have biased our results toward the null.
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between individuals with and without
periodontal care in our study may have
been due to our ability to adjust more
completely for important confounders.
Our analyses adjusted for covariates that
capturedmedicalcareutilizationandpre-
ventivehealthbehaviors,variablesnotin-
cluded in other studies. However, we
could not control for some adjusters used
in other studies, including antibiotic use,
numberofteeth,race,socioeconomicsta-
tus, and use of nonsteroidal anti-
inﬂammatory medications. Although we
couldnotcontrolforthesecovariates,our
analysis may have partially accounted for
thembecauseofthefollowing:ourcohort
was primarily Caucasian (75%); most,
due to local policy, were using statins,
which have anti-inﬂammatory effects;
and the population was dual medical/
dental insured, which may reduce differ-
ences in socioeconomic status. No study,
including our own, has controlled for nu-
tritional status beyond BMI. If poor nutri-
tion is associated with both increased
periodontal care (as a marker for peri-
odontitis) and increased GHb, our inabil-
ity to control for potential confounding
bynutritionalstatuscouldbiasourresults
toward ﬁnding an association when none
exists.
Our stratiﬁed analysis suggested that
the magnitude of the association between
periodontal care and GHb may be greater
in younger diabetic subjects (age 40–49
Table 1—Select characteristics by periodontitis status of our analysis sample (n  5,103) of a continuously enrolled diabetic population, age
40–70 years, with medical and dental insurance and at least one dental and one medical visit during the study years 2002–2006
Total
No periodontal
care
Periodontal
care P*
n 5,103 3,153 1,950 —
Average 5-year GHb % 7.66 	 1.3 7.62 	 1.3 7.72 	 1.4 0.01
Average number of GHb tests/5 years 7.56 	 4.4 7.62 	 4.4 7.46 	 4.3 0.19
Age (years)
40–49 (n  1,308) 26 25 26 0.01
50–59 (n  2,466) 48 47 50
60–70 (n  1,329) 26 28 24
Sex (female) 45 48 40 0.001
Smoking status during 5-year study period†‡
Nonsmoker 86 87 83 0.001
Intermittent smoker 9 8 10
Continuous smoker 5 5 6
Preventive service use
Average number well-care visits/5 years 1.10 	 1.1 1.10 	 1.1 1.09 	 1.1 0.65
Average number retinal eye exams/5 years 4.04 	 4.2 4.13 	 4.2 3.91 	 4.2 0.08
Ambulatory service use
Average primary care visits/5 years 21.90 	 16.6 22.65 	 17.4 20.70 	 15.2 0.001
Average specialty visits/5 years 11.99 	 11.8 12.47 	 12.2 11.21 	 11.2 0.001
Insurance type 2002‡ 0.001
Medicare 12 14 10
Individual 2 2 2
Commercial 24 24 26
Government 61 60 63
Other 0 0 0
Diabetes Complication Severity Index
2002–2003
0:0 49 49 49 0.1
1:1 23 23 25
2:1 2 82 82 6
Diabetes treatment intensity 2002–2006 0.93
0:No hypoglycemic medication 23 22 23
1:Oral hypoglycemics only 46 46 46
2:Any insulin 31 32 31
RxRisk (comorbidity score) 2002†
201–1,440 25 24 27 0.004
1,441–2,750 25 25 25
2,751–4,560 25 25 25
4,561 25 26 23
Average median BMI (ﬁrst three
measurements in 2002–2006)† 33.72 	 7.3 33.95 	 7.4 33.36 	 7.0 0.006
Data are means 	 SD or percent unless otherwise indicated. *We used Pearson 
2 for categorical variables and ANOVA F tests for continuous variables to test
differencesinpercentsandmeansofpopulationcharacteristicsbyperiodontitisstatus.†Countsformissingdata:smokingn2,RxRiskn2,BMIn187(3.6%).
‡Percentages do not add up to 100 because of rounding.
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cautiously given the 0.10 signiﬁcance of
the interaction term. The study of people
of Pima ancestry who had diabetes re-
ported a similar ﬁnding. When periodon-
titis was deﬁned based on bone loss, the
association with GHb was observed only
inpatientsage35years.However,since
we could not control for number of teeth,
another explanation is that we are not
capturing periodontitis as well in older
adults, who tend to need less periodontal
treatment because they have lost more
teeth.
In an exploratory analysis, we ob-
served a higher magnitude of association
between periodontal care and GHb level
in women than in men. We may have less
measurement error in GHb in women be-
cause of their higher health care use.
Women, compared with men, had
slightlyhighermeannumberofGHbtests
performed during the 5 years (7.9 vs.
7.5). Men and women did not differ in
baseline or 5-year mean GHb levels, dia-
betes treatment intensity, or diabetes
complication severity index. This ﬁnding
is intriguing because some literature links
increases in proinﬂammatory cytokines
with declining estrogen in menopause
(24), during which the average age is 51
years,closetoourfemalepopulation’sav-
erage age of 54 years. Assuming similar
measurement error and increased gener-
alizedinﬂammatoryburdenwitheachde-
cade of women’s age, we might expect to
see a lower magnitude of association with
increasing age, which our data suggested
(age 40–49 years, 0.35 percentage points
higher; age 50–59 years, 0.14 higher; age
60–70years,0.09higher);however,theP
value for the interaction term was not sig-
niﬁcant (P  0.19). Additionally, a recent
study, which used survey data and evalu-
atedtemporalsequence,reportedastron-
ger association between periodontal
disease and incident diabetes in women
versus men (25). Our ﬁnding needs fur-
ther corroboration.
In participants with diabetes who re-
ceived periodontal care, we observed
lower GHb with greater intensity of peri-
odontal treatment, but the magnitude of
this association was small. These results
are consistent with a recent meta-analysis
ofninesmallrandomizedcontrolledtrials
(485individuals)supportingtheideathat
periodontal treatment improves glycemic
control (15). An earlier meta-analysis of
10 intervention studies reported nonsig-
niﬁcant results (16). The relatively small
magnitude of the association in our study
may be due to our use of dental claims
and the fact that all patients in this group
received at least some periodontal care.
Our measure of periodontal treatment in-
tensity may have nondifferential mea-
surementerror,sinceitdoesnotprecisely
measure the scope or type of treatment,
which could bias our results. Or, the
Table 2—Multivariate linear regression analysis: annual mean GHb modeled as a function of
periodontitis status in diabetic patients with medical and dental insurance, age 40–77 years,
and at least one medical and dental visit during the 5-year study period
n
Difference in mean GHb
among patients who did
and did not receive
periodontal care P
Lower
CI
Upper
CI
Unadjusted 5,103 0.11 0.005 0.03 0.19
Age, BMI, and sex adjusted 5,102 0.09 0.02 0.01 0.17
Multiple adjustment* 5,099 0.08 0.04 0.005 0.16
Multiple adjustment and
controlling for severity
of diabetes† 5,099 0.08 0.02 0.01 0.15
*Covariatesincludedinmodel:age,BMI,sex,RxRiskin2002,smokingstatus,numberofprimarycarevisits
(square root), number of specialty care visits (square root), number of well visits (square root), and number
of GHb tests (square root). †In addition to covariates mentioned above, this model also included diabetes
treatment level (no medication for diabetes, oral glycemic medication only, or any insulin) and Diabetes
Complication Severity Index variables.
Table 3—Stratiﬁed analysis: annual mean GHb modeled as a function of periodontitis status
in multivariate linear regression models in diabetic patients, age 40–70 years, with medical
and dental insurance and at least one medical and dental visit during the 5-year study period
Stratiﬁcation variable* n
Difference in GHb
among patients who
did and did not receive
periodontal care Lower CI Upper CI
Interaction
P value
Sex 0.002
Female 2,261 0.18 0.08 0.28
Male 2,564 0.01 0.10 0.08
Age-group (years)† 0.10
40–49 1,223 0.20 0.04 0.36
50–70 3,602 0.04 0.03 0.11
Diabetes Complication
Severity Index 0.20
0 2,466 0.01 0.08 0.10
1 1,208 0.16 0.03 0.29
2 1,425 0.09 0.04 0.23
BMI (kg/m
2) 0.36
24.9 410 0.18 0.06 0.41
25–29.9 1,180 0.09 0.04 0.21
30–39.9 2,363 0.10 0.004 0.20
40 872 0.06 0.24 0.12
Insulin use 0.47
No insulin use 3,297 0.04 0.04 0.11
Insulin use 1,528 0.12 0.014 0.25
Smoking 0.34
Nonsmoker 4,145 0.10 0.03 0.17
Intermittent smoker 434 0.06 0.28 0.17
Continuous smoker 246 0.01 0.37 0.36
*Covariatesincludedinmodels:age,BMI,sex,RxRiskin2002,smokingstatus,numberofprimarycarevisits
(square root), number of specialty care visits (square root), number of well visits (square root), number of
A1C tests (square root), treatment level (no medication for diabetes, oral glycemic medication only, or any
insulin), and Diabetes Complication Severity Index variables. †Controlled for age within age-group.
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effectiveness of periodontal treatment de-
livered in experimental trials compared
with periodontal care provided in the
community.
Limitations are inherent to our
study’s design. As a cross-sectional study,
it cannot establish causality or temporal-
ity. In addition, since this study is obser-
vational, residual confounding may
explain the minimal difference in GHb
between people with diabetes who did
and did not receive periodontal care.
However, this study does support using
linked populations from medical and
dental providers and the associated auto-
mated data to expand research on the as-
sociation between oral health and other
medical conditions.
In this study, based on medical care
and dental claims data, we found a small
positive association between periodontal
care (a marker of periodontitis) and
higher GHb. In sub-analyses, these ﬁnd-
ings were stronger among women than
men,andwefoundthatamongthosewho
were treated for periodontitis, more in-
tensetreatmentwasassociatedwithlower
GHb.
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